Shop by goal

  • Metabolic Signalling
  • GH-Axis Research
  • Muscle & IGF Research
  • Tissue and Cellular Models
  • Regenerative Research
  • Cellular Senescence Research
  • Cognitive Research
  • Multi-Compound Blends
  • Accessories
  • All compounds →
  • Popular compounds

  • BPC-157
  • TB-500
  • GHK-Cu
  • Retatrutide
  • Semaglutide
  • Ipamorelin
  • All bestsellers →
  • Research resources

  • Research Areas
  • Certificates of Analysis
  • Research Glossary
  • Compare Compounds
  • Peptide Guides
  • Delivery Guide
  • Track Order
  • Recently viewed

  • All peptide guides
  • Crypto Blog
  • How to Reconstitute
  • Reconstitution Calculator
  • How to Store
  • Research
  • Certificates of Analysis
  • Sign In
  • Create Account
  • My Account
  • My Orders
  • My Referrals
  • Log Out
  • Track Order
  • Refer a Friend
  • Follow us on Twitter/X
  • How-to guides

    Melanotan-1: Tanning / Libido research guide

    In short: Afamelanotide (Melanotan I) linear 13-amino-acid α-MSH analogue selectively activates MC1R eumelanogenesis via cAMP-MITF cascade. FDA/EMA-approved for EPP treatment. It is studied in preclinical (cell and animal) research and is supplied strictly for laboratory use, not for human or clinical use.

    Not medical advice. Melanotan-1 is a research compound. This guide does not provide dosing, diagnosis, therapy recommendations, or claims about effects in humans.

    Melanotan-1 at a glance

    Compound type
    Research peptide
    Research category
    Tanning / Libido
    Also known as
    Melanotan I, MT-1, Afamelanotide, Scenesse, NDP-MSH, NDP-α-MSH, [Nle4,D-Phe7]-α-MSH, CUV1647, Selective MC1R Agonist
    Molecular weight
    1646.87 Da
    Research-grade purity
    >99% HPLC
    Evidence context
    Preclinical / research use only
    Regulatory status
    Not an approved medicine. Supplied as a research compound
    Last reviewed
    16 June 2026

    What to know first

  • Selective MC1R agonism activates cAMP-PKA-CREB-MITF transcriptional cascade for eumelanin biosynthesis
  • UV-independent melanogenesis provides photoprotection without requiring sun exposure
  • Eumelanin absorbs UVB, UVA, and visible light while scavenging reactive oxygen species
  • Enhances DNA repair processes and antioxidant activity via MC1R downstream signaling
  • Details and limits sit in the sections below. Research use only.

    What Melanotan-1 is

    Melanotan-1 (afamelanotide, Scenesse) is a selective MC1R agonist that drives UV-independent eumelanin production - the only melanocortin peptide currently FDA- and EMA-approved for human therapeutic use.

    One-paragraph overview from our research datasheet. Still scientific, but faster to read than the full mechanism list below.

    Afamelanotide (Melanotan I) linear 13-amino-acid α-MSH analogue selectively activates MC1R eumelanogenesis via cAMP-MITF cascade. FDA/EMA-approved for EPP treatment.

    Research contexts

    Peer-reviewed papers discuss Melanotan-1 in specific lab settings. The points below reflect research questions, not health claims.

    Research vs. personal use: Literature describes experiments in cells and animals. That is distinct from real-world use. Our products are for laboratory research only.

    Typical study contexts

  • Melanocortin receptor pharmacology in animal or cell systems.
  • UV-response pathways studied for mechanism, not human tanning advice.
  • Selective MC1R agonism activates cAMP-PKA-CREB-MITF transcriptional cascade for eumelanin biosynthesis.
  • UV-independent melanogenesis provides photoprotection without requiring sun exposure.
  • Eumelanin absorbs UVB, UVA, and visible light while scavenging reactive oxygen species.
  • Enhances DNA repair processes and antioxidant activity via MC1R downstream signaling.
  • Why Tanning / Libido research matters

    These peptides are studied for melanocortin receptor biology and pigmentation. That work is separate from consumer tanning products.

    Mechanisms (technical review)

    Our datasheet lists mechanistic themes from preclinical work. These are research endpoints, not health claims.

  • Selective MC1R agonism activates cAMP-PKA-CREB-MITF transcriptional cascade for eumelanin biosynthesis
  • UV-independent melanogenesis provides photoprotection without requiring sun exposure
  • Eumelanin absorbs UVB, UVA, and visible light while scavenging reactive oxygen species
  • Enhances DNA repair processes and antioxidant activity via MC1R downstream signaling
  • Effective in MC1R variant allele carriers (Val60Leu, Asp84Glu, Arg151Cys, Arg160Trp)
  • D-Phe7 substitution confers resistance to endopeptidase degradation with prolonged duration of action
  • Lab handling & preparation

  • Storage: Lyophilised powder: store in freezer (−20 °C). Reconstituted: refrigerate 1–6 °C, away from sunlight. Use within the validated stability window for the specific batch and formulation.. See the storage guide.
  • Research dosing context: Literature typically discusses 0.5-1.0 mg subcutaneously or 16 mg implant (Scenesse). Subcutaneous injection daily or every other day; implant every 60 days (EPP) Full SC bioavailability; no oral or transdermal bioavailability detected. Nle4 substitution prevents methionine oxidation; D-Phe7 resists proteolysis. Implant formulation provides controlled release at lower effective doses than daily injections. Non-immunogenic per long-term clinical follow-up. CAS 75921-69-6.
  • Preparation: Follow the reconstitution guide. Confirm volumes with the calculator.
  • Purity check: Use the COA reading guide and the published Melanotan-1 Certificate of Analysis.
  • Common Questions People Are Asking

    What is Melanotan-1?

    Melanotan-1 (afamelanotide, MT-1) is a synthetic linear 13-amino-acid analogue of α-MSH ([Nle4,D-Phe7]-α-MSH, MW ~1647 Da) that selectively activates the melanocortin-1 receptor (MC1R) to drive eumelanin synthesis. It is the molecule approved as Scenesse (a 16 mg implant) for erythropoietic protoporphyria. New-U supplies it as a research-grade lyophilised powder for laboratory research use only — not the approved drug and not for human use.

    How is Melanotan-1 different from Melanotan-2?

    MT-1 is a linear 13-amino-acid peptide that is relatively selective for MC1R (pigmentation). MT-2 is a cyclic 7-amino-acid peptide that hits all four melanocortin receptors non-selectively, which is why research reports it producing appetite suppression, nausea, and central arousal effects that MT-1 largely avoids. MT-1 is also the only one of the two FDA/EMA-approved for any indication. These are research distinctions only; both are supplied for laboratory research, not human use.

    What does the research on Melanotan-1 actually show?

    The strongest data is in erythropoietic protoporphyria: a randomised phase 3 trial (Langendonk et al., NEJM 2015) reported that afamelanotide increased pain-free time in sunlight for EPP patients, which supported its EMA and FDA approval as Scenesse. Mechanistically, studies describe reliable MC1R-driven eumelanin accumulation without the central effects of non-selective analogues. This is summarised published research, not a human-use claim.

    Does MT-1 work in people with fair skin or MC1R variants?

    In the research literature, yes. Afamelanotide's clinical trial program tested populations carrying MC1R variant alleles (such as Val60Leu, Arg151Cys, and Arg160Trp) associated with weak natural pigmentation, and reported a pigmentation response even in those genotypes — one reason it was approved for EPP. Reported for research context only.

    What is the half-life of Melanotan-1 described in the literature?

    Published pharmacology describes a short plasma half-life of roughly 30 minutes after subcutaneous administration, but the studied biological pigmentation effect persists for several days because MC1R activation and slow receptor recycling outlast the circulating peptide. The Nle4 substitution prevents methionine oxidation and D-Phe7 resists proteolysis, extending activity versus native α-MSH. This is descriptive research context — not human-use dosing guidance.

    What does "UV-independent" pigmentation actually mean?

    Normal tanning requires UV damage — skin darkens as a response to DNA damage from sun exposure. MT-1 activates the same downstream pigmentation pathway (MC1R / cAMP / MITF / tyrosinase) directly at the receptor level, so in research models pigment accumulates without the upstream DNA-damage signal. The protective pigment is the same; only the trigger differs. Reported for research context only.

    Is Melanotan-1 legal and FDA-approved?

    The finished pharmaceutical afamelanotide (Scenesse) is FDA- and EMA-approved for erythropoietic protoporphyria — that approval applies to the prescription implant, NOT to research-grade powder. New-U's Melanotan-1 is an unapproved research compound supplied strictly for laboratory research, labelled research use only and not for human consumption; buyers are responsible for compliance in their own jurisdiction.

    How should MT-1 be stored and reconstituted?

    Keep the lyophilised powder frozen at −20 °C. For research preparation it is dissolved in bacteriostatic water; the reconstituted vial is then refrigerated at 1-6 °C and protected from light. The linear structure is slightly more sensitive than cyclic MT-2, so prompt use after reconstitution is preferable. This is laboratory handling information only, not a human-use instruction.

    Is this page medical advice? Can I use Melanotan-1 for my health?

    No, and no. This article is educational only. We do not provide dosing, medical recommendations, or health claims. Our products are sold strictly for laboratory research, not for personal use of any kind.

    Where do I find Melanotan-1 specs, purity certificates and pricing?

    Open the shop listing via “View product details.” There you will see batch specs, the Certificate of Analysis (COA), concentration, purity grade, and available SKUs with current pricing.

    Related peptide guides

    Other compounds researchers often read about alongside Melanotan-1.

  • Melanotan-2 - companion guide
  • PT-141 - companion guide
  • Oxytocin Acetate - companion guide
  • TB-500 - companion guide
  • Scientific sources & further reading

    Primary literature and registries for Melanotan-1, plus mainstream coverage of the peptide category. Research use only - not medical advice.

    Databases & literature:

  • PubMed: peer-reviewed literature on Melanotan-1
  • ClinicalTrials.gov: registered studies on Melanotan-1
  • Melanotan-1: Wikipedia
  • Peptides in the news:

  • WebMD: consumer health reference
  • BBC News: Health
  • CNN Health: “Peptides: what to know about the wellness trend”
  • Sky News: “Can peptides make America healthy again?”
  • Sky News: “Inside the exploding US peptides craze” (video)
  • Sky News Australia: “Black market peptide trade explodes as influencers fuel uptick in use”
  • Sky News Australia: “Backyard peptide boom sparks alarm” (video)
  • Sky News Australia: “Oprah reveals struggle with shame of weight-loss drugs”
  • Ready to order? View full product specs

    Access concentration, batch info, variants, and current pricing on our shop.

    Also known as: Melanotan I, MT-1, Afamelanotide, Scenesse, NDP-MSH, NDP-α-MSH, [Nle4,D-Phe7]-α-MSH, CUV1647, Selective MC1R Agonist

    PRECISION. PURITY. PERFORMANCE.

    Research peptides at >99% HPLC-verified purity, third-party tested by Janoshik Analytical & Freedom Diagnostics, with Certificates of Analysis published per released batch. Supplied strictly for laboratory research use.

    Shop

  • All research compounds
  • Price list
  • Where to buy peptides
  • Compare compounds
  • Compare vial sizes
  • Affiliate programme
  • Research

  • Peptide 101
  • Published COAs
  • Research areas
  • Research blog
  • How-to guides
  • Peptide guides
  • Research glossary
  • Support

  • Track your order
  • Contact us
  • Shipping & delivery
  • FAQ
  • Community forum
  • Customer reviews
  • Refund policy
  • Ways to Pay

  • Google Pay
  • Apple Pay
  • Venmo
  • PayPal
  • Cryptocurrency
  • Cash App
  • Card payments
  • Bank transfer (SEPA)
  • Paying with crypto
  • Live crypto prices
  • Shop by goal

  • Metabolic Signalling
  • GH-Axis Research
  • Muscle & IGF Research
  • Tissue and Cellular Models
  • Regenerative Research
  • Cellular Senescence Research
  • Cognitive Research
  • Multi-Compound Blends
  • Accessories
  • Shop by compound

  • BPC-157
  • TB-500
  • GHK-Cu
  • Tesamorelin
  • Semaglutide
  • CJC-1295 (without DAC)
  • Ipamorelin
  • MOTS-C
  • All compounds →
  • Shop by region

  • United Kingdom
  • Australia
  • Canada
  • Canada (FR)
  • Ireland
  • Malta
  • Germany
  • France
  • Spain
  • Italy
  • Netherlands
  • Portugal
  • Greece
  • Austria
  • Poland
  • Sweden
  • Finland
  • Denmark
  • Norway
  • Croatia
  • Slovakia
  • Slovenia
  • Estonia
  • Latvia
  • Lithuania
  • Czechia
  • Hungary
  • Romania
  • Bulgaria
  • Belgium
  • Belgium (FR)
  • Luxembourg
  • United States
  • Northern Ireland
  • Research use only (RUO). All products are sold strictly for laboratory and research purposes — not for human or veterinary consumption. Purchasers must be 21 or older.

    All rights reserved. Copyright of New-U held with Hilxera Distribution Services LLC 2026.

    Website & business operated by Hilxera Distribution Services LLC. Registered in Wyoming, ID: 2026-001928701.

    © 2026 New-U Research Compounds · new-u.io

    Research use only — not for human consumption. All products are supplied strictly for laboratory research purposes.

    © 2026 New-U Research Compounds · new-u.io — Copyright held with Hilxera Distribution Services LLC. All rights reserved.